The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IMS 2022 | The role of ER-phagy in multiple myeloma cell survival
Simone Cenci, MD, IRCCS Ospedale San Raffaele, Milan, Italy, comments on the role of endoplasmic reticulum autophagy (ER-phagy) in the survival of multiple myeloma cells, highlighting the potential of manipulating this mechanism as a novel therapeutic strategy. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
